Скачать с ютуб Leishmaniasis drug discovery в хорошем качестве

Leishmaniasis drug discovery

Panel at the annual conference ISNTD d³ 2021 by the International Society for Neglected Tropical Diseases (this year online), discussing recent trends, challenges and breakthroughs in drug discovery for leishmaniasis, covering both cutaneous and visceral leishmaniasis. The full session with the following panellists and their presentations can be viewed here. The individual presentations are also available in separate videos as follows: Prof Maria Paola Costi (Drug Discovery and Biotechnology Lab, University of Modena and Reggio Emilia, UNIMORE) - "Visceral leishmaniasis: the discovery & clinical landscape" -    • Visceral leishmaniasis: the discovery...   Dr Fabiana Alves (Head of Visceral Leishmaniasis Clinical Programme, DNDi) - "Current and future perspectives for the development of new treatments for visceral leishmaniasis" -    • Current and future perspectives for t...   Dr Byron Arana (Head of Cutaneous Leishmaniasis, DNDi) - "Cutaneous leishmaniasis: from bench to cure" -    • Cutaneous leishmaniasis: from bench t...   Prof Dolores Carrer (Biophysics and Nanotechnology Lab, INIMEC-CONICET-UNC, Argentina) - "Topical treatments for cutaneous leishmaniasis" -    • Topical treatments for cutaneous leis...   Recorded at ISNTD d³ 2021 (online), the annual conference on drug discovery, development and diagnostics for tropical diseases organised by the International Society for Neglected Tropical Diseases. Website: www.isntd.org/isntd-d3